Rheumatrex re-launched
Executive Summary
Stada Pharmaceuticals is re-introducing Rheumatrex (methotrexate) for moderate to severe rheumatoid arthritis. Stada purchased the agent from Wyeth in 2002 and was approved by FDA to market it in October...
Latest Headlines
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
PS043992
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.
All fields are required.
PS043992
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.